BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23756979)

  • 1. Quality of life and depressive symptoms in Parkinson's disease after subthalamic deep brain stimulation: a 2-year follow-up study.
    Tykocki T; Szalecki K; Koziara H; Nauman P; Mandat T
    Turk Neurosurg; 2013; 23(3):379-84. PubMed ID: 23756979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
    Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
    Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
    Daniels C; Krack P; Volkmann J; Raethjen J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G; Witt K
    Mov Disord; 2011 Dec; 26(14):2516-21. PubMed ID: 22170276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of bilateral deep brain stimulation of the subthalamic nucleus on depression in patients with Parkinson's disease.
    Wang X; Chang C; Geng N; Li N; Wang J; Ma J; Xue W; Zhao W; Wu H; Wang P; Gao G
    Parkinsonism Relat Disord; 2009 Sep; 15(8):587-91. PubMed ID: 19403325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in quality of life following subthalamic stimulation for Parkinson's disease.
    Hariz GM; Limousin P; Zrinzo L; Tripoliti E; Aviles-Olmos I; Jahanshahi M; Hamberg K; Foltynie T
    Acta Neurol Scand; 2013 Oct; 128(4):281-5. PubMed ID: 23550919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's disease.
    Nazzaro JM; Pahwa R; Lyons KE
    Parkinsonism Relat Disord; 2011 Sep; 17(8):606-9. PubMed ID: 21669545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits.
    Castelli L; Perozzo P; Zibetti M; Crivelli B; Morabito U; Lanotte M; Cossa F; Bergamasco B; Lopiano L
    Eur Neurol; 2006; 55(3):136-44. PubMed ID: 16682797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease.
    Dafsari HS; Ray-Chaudhuri K; Mahlstedt P; Sachse L; Steffen JK; Petry-Schmelzer JN; Dembek TA; Reker P; Barbe MT; Visser-Vandewalle V; Fink GR; Timmermann L
    Eur J Neurol; 2019 Feb; 26(2):222-e17. PubMed ID: 30107062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significant improvement of motor symptoms by deep brain stimulation of bilateral subthalamic nucleus in patients with moderate or advanced Parkinson's disease].
    Chen J; Liu JL; Chen X; Qian H; Xian WB; Zhou HY; Liu YM; Ye XF; Zheng YF; Zhang SL; Chen L; Li JR; Liu ZL; Pei Z
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(5):291-5. PubMed ID: 21419000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep-wake functions and quality of life in patients with subthalamic deep brain stimulation for Parkinson's disease.
    Bargiotas P; Eugster L; Oberholzer M; Debove I; Lachenmayer ML; Mathis J; Pollo C; Schüpbach WMM; Bassetti CL
    PLoS One; 2017; 12(12):e0190027. PubMed ID: 29253029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease.
    Liang GS; Chou KL; Baltuch GH; Jaggi JL; Loveland-Jones C; Leng L; Maccarone H; Hurtig HI; Colcher A; Stern MB; Kleiner-Fisman G; Simuni T; Siderowf AD
    Stereotact Funct Neurosurg; 2006; 84(5-6):221-7. PubMed ID: 17063043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatology.
    Tröster AI; Fields JA; Wilkinson S; Pahwa R; Koller WC; Lyons KE
    Stereotact Funct Neurosurg; 2003; 80(1-4):43-7. PubMed ID: 14745208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of deep brain stimulation of the subthalamic nucleus on non-motor fluctuations in Parkinson's disease: two-years' follow-up.
    Ortega-Cubero S; Clavero P; Irurzun C; Gonzalez-Redondo R; Guridi J; Obeso JA; Rodriguez-Oroz MC
    Parkinsonism Relat Disord; 2013 May; 19(5):543-7. PubMed ID: 23453890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.